This troubles me deeply, because if we look at international and national guidelines, we have recommendations for first-, second- and third-line therapies. Those are both pharmacological and non-pharmacological treatments. Many Canadians, as we know, have difficulty accessing first-line treatments to get access to treatments that have less evidence but have shown effectiveness for some individuals. I just don't see that happening in our country. I'm sure there are statistics that would support that.
